(firstQuint)Pharmacokinetics Study of Donepezil HCl in Subjects Receiving Haemodialysis.

.

 This is a randomised, single-center, open-label, single-dose, two-period crossover pharmacokinetics study of donepezil HCl tablets 3 mg in subjects receiving haemodialysis.

 Subjects will be or will not be receiving haemodialysis.

 After intervals of over 15 days, the subjects will be receiving the other treatment.

.

 Pharmacokinetics Study of Donepezil HCl in Subjects Receiving Haemodialysis.

@highlight

The purpose of this study is to investigate the pharmacokinetics of donepezil HCl 3 mg in subjects with end-state renal disease who were receiving haemodialysis.

